SARS-CoV-2-IN-8

• UNSPSC Description:

  SARS-CoV-2-IN-8 is a SARS-CoV-2 main protease inhibitor with an IC50 value of 0.75 μM.

• Target Antigen:

  SARS-CoV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/sars-cov-2-in-8.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(N(C1)CC(C(O)C1(C)C2)(C)CN2C(C3=NN(C)C4=C3CCC5=C4C=CC=C5)=O)C6=NN(C)C7=C6CCC8=C7C=CC=C8

• Molecular Weight:

  590.71

• References & Citations:

  [1]Shcherbakov D, et al. Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors. ACS Med. Chem. Lett. 2021.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported